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The use of fast-atom bombardment ionization-tandem mass spectrometry approaches, with 
collision energies on the order of 30-50 eV, was developed for the analysis of low picomole 
quantities of polycyclic aromatic hydrocarbon dihydrodiol-epoxide deoxynucleoside adducts. 
This strategy combines three experimental techniques: (11 product ion scans, (2) constant 
neutral loss scans, and (3) precursor ion scans. Product ion scans of the protonated molecule 
or the BH: ion that results from loss of the deoxyribose were dominated by fragments 
associated with cleavage of the sigma bond between the dihydrodiol-epoxide moiety and the 
nucleobase. Constant neutral loss scans were based upon the loss of deoxyribose (116 u) or 
the combined loss of the deoxynucleoside, water, and carbon monoxide (313 u); precursor ion 
scans utilized the latter fragment. The formation of trimethylsilyl derivatives increased the 
sensitivity of analysis, which allowed the simultaneous detection of DNA adducts in a 
mixture. (I Am Sot Mass Syectr-onr 2995, 6, 248-256) 
P olycyclic aromatic hydrocarbons (PAHs) are a group of structurally related chemicals that con- stitute an important class of carcinogenic envi- 
ronmental pollutants [l]. These compounds, which are 
produced during combustion processes, are metabo- 
lized into electrophilic derivatives, typically dihydro 
diol-epoxides, that are capable of reaction with DNA 
to elicit mutagenic and carcinogenic responses [2]. The 
analysis of carcinogen-DNA adducts that result from 
PAH dihydrodiol-epoxides or electrophilic derivatives 
from other classes of carcinogens has been proposed as 
a means of evaluation of the extent of human exposure 
to specific carcinogens [3]. DNA adduct analyses are 
complicated, however, by the low frequency of DNA 
adduction that occurs in vivo. In experimental animals, 
for example, only about 10-100 pmol of adduct per 
milligram of DNA are normally formed following 
treatment with tumorigenic doses of carcinogens. This 
problem is further complicated by the fact that DNA is 
a minor component (about 0.1% by weight) of tissue. 
In addition, humans usually are exposed to smaller 
amounts of carcinogens than those used with experi- 
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mental animals, with resultant lower levels of DNA 
adduction [4]. 
Several techniques, which include immunoassays 
[5], fluorescence assays [6], and a2P-postlabeling [7], 
have been developed for the analysis of small quanti- 
ties of carcinogen-DNA adducts. Although they are 
highly sensitive, these methods do not permit struc- 
ture elucidation, which is a severe limitation when 
there is uncertainty with regard to the nature of the 
carcinogen exposure. Mass spectrometry has the poten- 
tial to provide structural information and, as such, has 
played an important role in the structural elucidation 
of covalently modified nucleic acids [S]. 
High resolution electron impact mass spectrometry 
(EI-MS) has been used to determine the structures of 
several PAH dihydrodiol-epoxide DNA adducts [9]. 
However, the extreme polarity and thermal lability of 
these adducts necessitated the formation of methyl or 
silyl ethers prior to analysis via electron impact (EI) 
ionization. Because of the combined sensitivity losses 
associated with the use of high resolution and TMS 
derivatization, alternatives to the high resolution EI-MS 
method for measurement of adduct levels in human 
DNA warrant investigation, particularly for analyses 
that involve unknown carcinogen-DNA adducts. 
Significantly less work has been reported on the 
tandem mass spectrometry of PAH dihydrodiol- 
epoxide DNA adducts. A deoxyguanosine adduct of 
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nnti-benzo[ a]pyrene-7,8-dihydrodiol-9,10-epoxide 
(nnti-BaPDE) was characterized by tandem mass spec- 
trometry methods that used field desorption (FD) ion- 
ization and collision-induced dissociation (CID) under 
high collision energy (8 keV) conditions [lo, 111. The 
fragment ions generated in the presence of the helium 
collision gas were readily interpretable in terms of the 
assigned structure and were similar to fragment ions 
observed in EI mass spectra of the permethylated 
adduct [91. Fast-atom bombardment (FAB) product-ion 
mass spectrometry studies of BaPDE adducts recently 
have been conducted via a VG Analytical (Fisons, 
Danvers, MA) ZAB-T four-sector (BEBE) mass spec- 
trometer [ 121. The product ion spectra for these adducts 
were dominated by ions derived from the carcinogen 
moiety. Other tandem mass spectrometry analyses of 
dihydrodiol-epoxide adducts have been limited pri- 
marily to studies that concern the site of carcinogen 
attachment to the nucleobase [13, 141. A relatively 
limited number of tandem mass spectrometry studies 
have been conducted with derivatized PAH-DNA 
adducts; however, trimethylsilyl (TMS) derivatives of 
deoxynucleoside-carcinogen adducts showed surpris- 
ing sensitivity by fast-atom bombardment-mass spec- 
trometry (FAB-MS), to an extent that appeared to be 
greater than EI-MS [15, 161. 
In this work, we report the development of FAB 
tandem mass spectrometry methods for the analysis of 
PAH dihydrodiol-epoxide deoxynucleoside adducts. 
This work, which is an extension of our previous 
studies with arylamine-DNA adducts [17], combines 
three experimental approaches: (1) constant neutral 
loss scans, (2) product ion scans of the protonated 
molecule or the BH: ion that results from loss of 
deoxyribose, and (3) precursor ion scans. We show that 
the sensitivity for analysis is increased by formation of 
TMS derivatives, which allows detection of PAH dihy- 
drodiol-epoxide deoxynucleoside adducts at low pico- 
mole levels. In addition, we demonstrate that FAB 
tandem mass spectrometry, especially of derivatized 
adducts, provides a rapid, sensitive, and selective 
method for the analysis of complex mixtures, often 
with minimal, if any, sample cleanup. 
Experimental 
Materials 
The following PAH dihydrodiol-epoxides were pur- 
chased from the NC1 Chemical Carcinogen Reference 
Standard Repository (Midwest Research Institute, 
Kansas City, MO): rnzli-benzo[ klfluoranthene-trnizs- 
8,9-dihydrodiol-lO,ll-epoxide (anti-benzo[ klfluor- 
anthene dihydrodiol-epoxide), anti-benzo[ blfluor- 
anthene-trans-9,10-dihydrodiol-11,12-epoxide (nnfi- 
benzo[ blfluoranthene dihydrodiol-epoxide), nnti-chry- 
sene-trarzs-1,2-dihydrodiol3,4-epoxide (nnti-chrysene 
dihydrodiol-epoxide), air&benz[ nlanthracene-trafzs- 
3,4-dihydrodiol-1,2-epoxide (njlti-be& nlanthracene 
dihydrodiol-epoxide), nizti-dibenz[ n,c]anthracene- 
trnrzs-lO,ll-dihydrodiol-12,13-epoxide (anti- 
dibenz[ a,c]anthracene dihydrodiol-epoxide), and anti- 
BaPDE. N-Trimethylsilylimidazole in pyridine (TMSI; 
Tri-Sil “Z”) was acquired from Pierce Chemicals 
(Rockford, IL). 7,8,9,10-Tetrahydroxy-7,8,9,10- 
tetrahydrobenzd nlpyrene was prepared by treating 
nnti-BaPDE with dilute hydrochloric acid for 18 h at 
37 “C. 
Adduct Synthesis and Deriuatization 
Covnle~t nzodificntion of DNA by dihydrodiol-cpoxides of 
PAHs. To 1.2 mg of salmon testes DNA (Sigma 
Chemical Co., St. Louis, MO) in 1 mL of 5-rnM Bis- 
Tris-HCl (Sigma), O.l-mM EDTA, pH 7.1, was added 
159 pg of anti-BaPDE in 107 FL of tetrahydrofuran. 
The mixture was allowed to react at 37 “C for 24 h and 
then was extracted with 1 mL of redistilled phenol 
saturated with an equal volume of 50-mM Bis-Tris-HCl, 
1-mM EDTA, pH 7.1. Additional extractions were con- 
ducted with a mixture of 500 PL of phenol and 500 ILL 
of Sevag (chloroform:isoamyl alcohol, 24:1), and then 1 
mL of Sevag. To the aqueous phase was added 100 PL 
of 5-M NaCl and 1.1 mL of cold ethanol. The precipi- 
tated DNA was collected by centrifugation, washed 
twice with 70% ethanol, and added to 1 mL of 5-mM 
Bis-Tris-HCl, O.l-mM EDTA, pH 7.1. The level of mod- 
ification, as determined by UV spectrometry, with an 
E 3,7 = 29,000 mM-’ [18], was 1.96%. The modified DNA 
was hydrolyzed as previously described [191 and the 
adducts were purified by high performance liquid 
chromatography (HPLC) with a 3.9-X 300-mm 
PBondapak C,, column (Waters Associates, Milford, 
MA) and a 30-min linear gradient of 20-100% methanol 
at a flow of 2 mL/min. A 500-MHz ‘H-NMR spectrum 
of the major adduct was obtained and it was consistent 
with N’-deoxyguanosine substitution at Cl0 of alzti- 
BaPDE. Similar procedures were used for reactions 
with the other PAH dihydrodiol-epoxides. The levels 
of modification from these dihydrodiol-epoxides were 
estimated by UV spectrometry by using the molar 
absorptivity value for the dihydrodiol-epoxides pro- 
vided by the supplier. 
Rmction between nucleosides with anti-BnPDE. To 10 
mg of deoxyguanosine (U.S. Biochemical, Cleveland, 
OH; 35 pmol) in 500 ILL of dimethylsulfoxide (DMSO) 
was added 60 Fg of nnti-BaPDE (0.2 pmol) and 10 PL 
of triethylamine. After 24 h at 37 “C, the reaction 
mixture was evaporated, 1 mL of water was added, 
and the mixture was extracted three times with diethyl 
ether to remove residual nrzti-BaPDE and degradation 
products. The aqueous phase was then applied to a 
C-18 Sep-Pak (Waters Associates), eluted with water to 
remove unreacted deoxyguanosine, and then eluted 
with methanol to recover the deoxyguanosine adduct 
in 18% yield. The adduct was further purified by 
HPLC, with a PBondapak column and the solvent 
250 BRANCO ET AL. 
conditions described previously. The same procedure 
was used with deoxyadenosine and deoxycytidine. ‘H- 
NMR spectra were obtained for the deoxyadenosine 
and deoxycytidine adducts and both were consistent 
with exocyclic amine substitution at Cl0 of anti-BaPDE. 
Reaction between nucleoside bases and anti-BaPDE. To 
12.7 mg of guanine (Sigma; 84 pmol) in 1 mL of DMSO 
was added 200 pg of anti-BaPDE and 30 PL of trieth- 
ylamine. Because the guanine was insoluble, the reac- 
tion was heated to 60 “C. HPLC analysis after 24 h 
indicated the formation of a product in very low yield. 
Due to the low yield, the adduct was not isolated and 
FAB tandem mass spectrometry was performed di- 
rectly on the reaction mixture. The same procedure 
was used with adenine and cytosine, except that the 
reactions were conducted at 37 “C for 24 h. 
Derivatization procedures. Adducts were silylated by 
adding 10 I.LL of TMSI to 1 pg of dry sample and 
heating at 65 “C for 2 h. The sample was then dried in 
vacua and diluted with DMSO prior to analysis. When 
modified DNA was analyzed, 100 FL of TMSI was 
added to the hydrolyzed samples. 
Mass Spectronzet y 
After application of 1-2 PL of thioglycerol FAB matrix 
liquid, 0.5-1.0 PL of a solution that contained the 
sample was applied directly to a copper target with a 
syringe. Spectra were obtained via a Finnigan-MAT 
(San Jose, CA) TSQ-70 with an Ion Tech (Middlesex, 
UK) gun. FAB ionization was effected by using xenon 
atoms accelerated to 8-10 keV. Scans were obtained 
from approximately 50-700 u under control of the 
TSQ-70 data system. Constant neutral loss scans were 
acquired by scanning the first and last quadrupoles 
(Ql and Q3) at the same rate, with a constant mass 
offset that corresponded to either the mass of the 
deoxyribose moiety (116 u) or the loss of 313 u. Prod- 
uct ion scans were obtained by fixing the mass passed 
by Ql to correspond to the protonated molecule or the 
BHZ ion, whereas Q3 was scanned to identify the 
masses of all the fragments formed by decomposition 
of the selected precursor ion. Precursor ion scans were 
obtained by selecting, with 43, a specific product ion, 
whereas the first analyzer (Ql) was scanned to select 
all precursor ions of that fragment. All scans were 
acquired by using argon as the collision gas. Collision 
energies of 30-50 eV were used and collision cell 
pressures were varied to maximize the yield of useful 
product ions. 
Results and Discussion 
We previously demonstrated that chemical derivatiza- 
tion coupled with FAB-MS is a sensitive method for 
the analysis of arylamine-DNA adducts 1171. In a 
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continuation of this work, we now have determined 
that FAB-MS is a sensitive technique for the detection 
of DNA adducts derived from PAH dihydrodiol- 
epoxides. We also have established the types of struc- 
tural information that can be obtained from FAB tan- 
dem mass spectrometry on these compounds. 
Fast-Atom Bombardment Mass Spectromety 
Compared to the arylamine-deoxynucleoside adducts 
we studied previously [ 171, the PAH-deoxynucleoside 
adducts gave very poor FAB full scan mass spectra. 
Figure la shows a FAB mass spectrum from 100 ng of 
the deoxyguanosine adduct obtained from anti-chry- 
sene dihydrodiol-epoxide. The ion of nz/z 546 corre- 
sponds to the protonated molecule and that at ,n/z 
430 to the BH: ion that results from loss of the 
deoxyribose moiety. Better results were obtained when 
the adducts were derivatized with TMSI; for example, 
the high mass region of a FAB mass spectrum for 5 ng 
of the anti-chrysene dihydrodiol-epoxide deoxyguano- 
sine adduct after TMSI derivatization is shown in 
Figure lb. The ions at m/z 646 and m/z 762 corre- 
spond, respectively, to tris-TMS derivatives of the BH: 
ion and the protonated molecule. The observation of a 
tris-TMS-modified BH: ion (m/z 646) 116 u lower in 
mass than the tris-TMS-derivatized protonated 
molecule indicates that for at least some of the 
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Figure 1. FAB mass spectra of anti-chrysene dihydrodiol- 
epoxide deoxyguanosine adduct (a) before and (b) after derivati- 
zation with Th4SI. Spectrum (a) was obtained with 100 ng of 
adduct, whereas spectrum (b) was recorded with 5 ng of Th4S- 
derivatized adduct. 
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TMS groups reside on the carcinogen and/or base. A 
more completely derivatized pentakis-TMS product 
would result from attachment of two, rather than no 
TMS groups to the deoxyribose moiety. Bis modifica- 
tion of the deoxyribose has been reported for aryl- 
amine-deoxynucleoside adducts [ 171, and was some- 
times observed in this study based on the observa- 
tion of weak protonated molecules for pentnkis- 
TMS-derivatized products. For example, the deoxy- 
cytidine-BaPDE adduct gave an ion (spectrum not 
shown) that corresponds to a penlakis-TMS protonated 
molecule. 
These results demonstrate the incomplete and 
sometimes variable TMS derivatization observed un- 
der the conditions used in this study. Attempts to use 
alternative derivatization strategies, including those 
already developed for arylamine-deoxynucleoside 
adducts, often resulted in decomposition of the PAH 
dihydrodiol-epoxide deoxynucleoside adducts. Never- 
theless, except as noted below for the deoxyadenosine 
adduct of anti-BaPDE, an abundant tris-TMS-deriva- 
tized protonated molecule was observed for all of 
the TMS-modified PAH dihydrodiol-epoxide adducts. 
With the deoxyadenosine adduct of anti-BaPDE, nei- 
ther a tris- nor a pentakis-TMSprotonated molecule 
was detected; only an ion that corresponds to the 
tris-TMS derivative of BH: was observed. 
Product Ions 
Underivatired adducts. To investigate the structural 
specificity of product ions from the adducts, and in 
particular, to determine if ions indicative of the site of 
base substitution could be identified, product ions 
were obtained from the protonated molecules of all the 
deoxyguanosine adducts. A FAB product ion spectrum 
of the protonated molecule (m/z 546) for the anti- 
benz[ alanthracene dihydrodiol-epoxide deoxyguano- 
sine adduct is shown in Figure 2. These results are in 
good agreement with data reported previously for FD 
3 
b 233 loo - 
2 60- Guo+’ H 2 
ml2 
Figure 2. FAB product ion spectrum of the protonated molecule 
(m/z 546) from 25 ng of anti-benz[ nlanthracene dihydrodiol- 
epoxide deoxyguanosine adduct. 
Scheme I. Proposed fragmentation pathway for the protonated 
molecules of PAH dihydrodiol-epoxide deoxynucleoside adducts. 
Initial cleavage of the C-N bond between the base and carcino- 
gen gives a carcinogen carbocation (fragment 1). Subsequent loss 
of 18 and 28 u gives fragments 2 and 3, presumably due to loss of 
water and carbon monoxide, respectively. The latter fragment 
was typically the base peak. The “boat-like” conformation of the 
cyclohexane ring is shown below fragment 1. 
and CID mass spectrometry of BaPDE deoxynucleo- 
side adducts [lo, 111. Except for the greater abundance 
of BH; ion, the spectrum is typical of the results 
observed with the other PAH dihydrodiol-epoxide de- 
oxyguanosine adducts. Fragment ions that correspond 
to loss of 267, 285, and 313 u from the protonated 
molecule were common to all of the spectra, and the 
proposed structures for these fragments, labeled 1, 2, 
and 3, respectively, are shown in Scheme I. An ion that 
corresponds to the protonated, unmodified base 
(guanine, m/z 152) also was observed from each of the 
deoxyguanosine adducts. Similar results, which in- 
clude fragments that correspond to 1, 2, and 3, were 
observed with deoxyguanosine-BaPDE, deoxyadeno- 
sine-BaPDE, and deoxycytidine-BaPDE adducts; how- 
ever, the mass loss that gives rise to ion 1 is dependent 
on the mass of the leaving group (nucleobase). With 
these deoxynucleoside adducts, ions that correspond 
to the protonated bases were noted at m/z 152 
(guanine), m/t 136 fadenine), and m/z 112 (cytosine). 
Many of the product ions from the protonated 
molecule are attributed to initial cleavage of the sigma 
bond between the carbon atom of the PAH dihydro- 
diol-epoxide and the exocyclic amine ( N2 for guanine) 
from the nucleobase. Formation of these ions can be 
explained based on the stability of carbocation struc- 
tures (1, 2, and 3), initial cleavage of single rather than 
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multiple bonds, and differences in the bond strengths 
for C-N sigma bonds in aromatic amines as com- 
pared to aliphatic amines. This is accomplished most 
easily by using, as a frame of reference, the protonated 
molecule where the proton resides on the exocyclic 
nucleobase nitrogen. Migration of the pair of electrons 
that form the sigma bond between this nitrogen atom 
and the PAH carbon gives a stable carbocation that 
results from heterolytic cleavage of the C-N bond. 
The absence of a significant signal for the ion that 
results from the alternative heterolytic C-N cleavage 
between the nucleobase and the same exocyclic amine 
is consistent with the observation that for exocyclic 
amines, the C-N bonds between an aromatic carbon 
(pyrimidine or purine) and an exocyclic amine are 
typically stronger than the same bond between a cyclic 
aliphatic carbon and an exocyclic amine (bond energies 
-4.4 and 3.7 eV, respectively [20]). After the initial 
formation of fragment 1, losses of water and then 
carbon monoxide result in the formation of two addi- 
tional carbocations, fragments 2 and 3, respectively. 
The protonated base ion results from cleavage of the 
same C-N bond that led to formation of ion 1 except 
that in this instance another hydrogen is transferred 
from the PAH to the amine nitrogen prior to cleavage. 
As a result the charge resides on the nucleobase side of 
the molecule. A proton transfer may be facilitated for 
the compounds investigated because of their confor- 
mation. The OH group on the opposite side of the 
cyclohexane ring is cis to the NH group and a “boat- 
like” conformation of the cyclohexane ring brings the 
NH and OH substituents on opposite sides of the 
cyclohexane ring into relatively close proximity 
(Scheme I). Such proximity and the resulting sharing of 
a proton was used to explain the relative stability (less 
fragmentation) of the cis isomer with respect to water 
loss in a study of protonated cis- and t~~~s-1,4-cyclo- 
hexanediols [21]. In the current study the greater 
propensity for fragmentation, as opposed to less frag- 
mentation from the cis-diols in ref 21, is attributed to 
the unequal sharing of a proton between nitrogen and 
oxygen. The proton affinity differences (typically about 
1 eV> favor protonation of the nitrogen rather than the 
oxygen atom. Transfer of the charge-bearing proton 
(Scheme I> from oxygen to nitrogen would lead di- 
rectly to fission of the PAH-nucleobase bond to give 
ion 1 (or the protonated base if the “extra” or charge- 
bearing proton happened to reside elsewhere on the 
nucleoside base). 
The absence of an analogous ion that contains the 
carcinogen moiety and the protonated amine can be 
attributed in part to the relative bond strengths cited 
previously, but additional factors such as the 
energy-entropy requirements for proton transfer from 
the nucleobase to the exocyclic amine likely play a role 
as well. The formation of ions 1, 2, and 3 could occur 
directly from the MH+ ion or indirectly via the BHT 
ion. The protonated base ion (m/z 152 in Figure 2) 
does not contain a deoxyribose sugar and is thus 
attributed to fragmentation from an intermediate BH: 
fragment. 
Model compounds for the BH: ions were synthe- 
sized by reaction of anti-BaPDE with guanine, ade- 
nine, and cytosine (Figure 3). A representative product 
ion spectrum for the guanine-BaPDE adduct is shown 
in Figure 4. The major fragments were the same as 
those observed from the protonated deoxynucleoside 
adducts, the structures of which were assigned in 
Scheme I. 
RamaKrishna et al. [12] have conducted FAB prod- 
uct ion studies of BaPDE adducts of adenine and 
guanine with a four-sector mass spectrometer. The 
adducts, which were synthesized by electrochemical 
oxidation, were endocyclic N7-substituted products as 
compared to the exocyclic N2- (guanine) and N6- 
fadenine) substituted adducts shown in Figure 3. Al- 
though their spectra were acquired by using high 
energy conditions, the CID spectra were dominated by 
ions derived from the BaPDE moiety, with fragments 
1, 2, and 3 (Scheme I) being readily apparent. These 
results suggest that product ion scans obtained from 
either low or high energy collisions provide structural 
information indicative of the molecular weights of the 
carcinogen and nucleobase, and perhaps some struc- 
tural features. Unfortunately neither method provides 
fragment ions that are conclusive with regard to the 
site of carcinogen substitution. 
Derizmtized addwts. Figure 5a shows a product ion 
scan (nz/r 570) of 25 ng of the anti-BaPDE de- 
oxyguanosine adduct, whereas Figure 5b presents the 
product ion spectrum (m/z 786) of 5 ng of the same 
BoPDE -Guo BoPDE -Ado 
BoPDE-Cy t 
Figure 3. Structures of nrlli-BaPDE guanine adduct (BaPDE- 
Gus), ml;-BaPDE adenine adduct (BaPDE-Ade), and mrbi-BaPDE 
cytosine adduct (BaPDE-Cyt). 
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ion is m/z 191. A product ion scan (not shown) of this 
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m/z 191 ion gave a base peak at m/z 73, which was 
il J” presumed to be (Si(CH,),)+. This suggests that the ion 
: 10 - 
i “1, 14’” 0 0 
@ 
of m/z 191 corresponds to [(tCH,),SiO),CHIC. An ion 
‘0 “o.q 0 0 
at m/z 191 has been reported in the mass spectra 
E on 0” of TMS derivatives of many polyhydroxy steroids; 
0 
a. Bole 
for example, a report by Brooks et al. 1221 details a 
z - do- 1 number of examples that show this and other rear- 
-, I,, ‘52 tw 
T b rangements that involve the migration of TMS L lo- 454 groups in mass spectra from trimethylsilyl ethers 
of steroids. Moreover, the structure of the m/z 
0 50 IbJ 150 353 191 ion was reported by Gustafsson et al. to be 
I,, [ TMSO= CH-OTMS] l [23]. 
Figure 4. FAB product ion spectrum of the protonated molecule 
(m/z 454) from arlli-BaPDE guanine adduct. 
adduct after derivatization with TM% These data are 
typical of the results observed with all of the TMS-de- 
rivatized deoxynucleoside adducts. Although greater 
sensitivity was obtained following derivatization, the 
product ion spectrum of the derivatized sample 
showed fewer fragments. For example, fragments that 
correspond to ions 1 and 3 in Scheme I (or TMS-de- 
rivatized analogs) were not observed with the deriva- 
tized adduct. A fragment that corresponds to 
bis-TMS-derivatized fragment 2 was present (in/z 429 
in Figure 5b); however, the most abundant fragment 
With derivatized adducts, the m/z 191 fragment 
ion was also the base peak in product ion scans of the 
nnti-BaPDE deoxyadenosine and deoxycytidine 
adducts. For the- other dihydrodiol-epoxide de- 
oxyguanosine adducts, the m/z 191 ion was promi- 
nent but the base peak was the protonated guanine 
base (m/z 152). 
Canstnnt Neutrd Loss Scans 
Uncieriunfized addiicts. A characteristic loss to produce 
a BH: ion has been observed in mass spectra obtained 
from protonated nucleosides and nucleotides [24-261, 
carcinogen-modified nucleosides [17, 27, 281, and sily- 
lated carcinogen-modified nucleosides [15, 161. By ex- 
tending this observation, we demonstrated the utility 
of constant neutral loss scans (116 ul for the determi- 
nation of nucleoside adducts of arylamines [17]. Con- 
stant neutral loss scans are particularly useful for anal- 
ysis of unknown adducts because they can be acquired 
prior to product ion spectra to determine the molecular 














Figure 5. FAB product ion spectra from the protonated molecule 
of arlli-BaPDE deoxyguanosine adduct (a) before (N/Z 570) and 
(b) after (VI/Z 786) derivatization with TMSI. Spectrum (a) was 
obtained with 25 ng of adduct, whereas spectrum (b) was 
recorded with 5 ng of TMS-derivatized adduct. 
Although many of the PAH dihydrodiol-epoxide 
adducts used in this study showed BH: ions as uni- 
molecular (Figure la) or collision-induced (Figure 2) 
fragments, others did not show loss of the deoxyribose, 
even with collisional activation of the protonated 
molecule (Figure 5aI. In all cases, the intensity of this 
ion was much less than was expected based on results 
previously reported for arylamine- and arylamide- 
modified deoxynucleosides 116, 171. Nevertheless, con- 
stant neutral loss scans that correspond to loss of 116 u 
were measured for all of the PAH dihydrodiol-epoxide 
adducts. For most of these adducts, loss of the deoxyri- 
bose from the protonated molecule, as well as the 
monosodium- and disodium-containing molecule ions, 
was observed (Figure 6a, for example). Another, more 
consistent type of constant neutral loss, based on the 
loss of 313 u, was observed for all of the deoxyguano- 
sine-PAH dihydrodiol-epoxide adducts studied. This 
loss, which is attributed to consecutive losses of the 
components of water, carbon monoxide, and de- 
oxyguanosine, gives rise to ion 3 in Scheme I. (The 
order of losses suggested in the scheme represents 
only one of several alternative mechanisms leading to 
an overall loss of 313 u.) Ion 3 is typically the base 




Figure 6. FAB constant neutral loss spectra of nnti- 
benzo[ klfluoranthene dihydrodiol-epoxide deoxyguanosine 
adduct. Spectrum (a) follows the loss of 116 u; spectrum fb) 
follows the loss of 313 u. Similar results were obtained with the 
anti-benzo[ blfluoranthene dihydrodiol-epoxide deoxyguanosine 
adduct. 
peak in product ion spectra of deoxyguanosine dihy- 
drodiol-epoxide adducts. Consequently, when constant 
neutral loss scans were compared from identical sam- 
ples, the loss of 313 u (Figure 6b) provided a more 
abundant signal than that observed with loss of 116 u 
(Figure 6a). 
Deriuatized udducts. Unsatisfactory results were ob- 
tained with the constant neutral loss spectra of TMS- 
derivatized PAH dihydrodiol-epoxide adducts. Al- 
though some adducts showed a loss of 116 u in prod- 
uct ion spectra (e.g., Figure Sb), this loss was not 
observed universally in product ion or constant neutral 
loss spectra. This can be attributed to alternative frag- 
mentation pathways to form ions that correspond to 2 
(Scheme I) or m/z 191. These results contrast with 
those previously obtained for TMS-derivatized aryl- 
amine adducts [171, where loss of 260 u (his-TMS 
derivatized deoxyribosel was observed for all of the 
arylamine adducts studied. In the present study, the 
hydroxyl groups unique to the dihydrodiol-epoxides 
were derivatized more readily (or the attached TMS 
groups were retained more readily) than those on the 
deoxyribose. Thus, constant neutral losses of 260 u can 
be measured only from protonated molecules of pen- 
tukis-TMS derivatives, and these were not always ob- 
served. 
Precursor 1072 Scans 
Underivutized adducts. Product ion spectra for anti- 
BaPDE adducts of deoxyguanosine, deoxyadenosine, 
and deoxycytidine showed a common base peak ion of 
nz/z 257 (fragment 3 in Scheme I). These results sug- 
gested that if the identity of the PAH was known, 
precursor ion scans could be used to elucidate the 
identity of the deoxynucleoside that had been modi- 
fied. Accordingly, when precursor ion spectra (257 u) 
were recorded for the three BaPDE adducts, proto- 
nated molecules were observed at m/z 570 (de- 
oxyguanosine), 554 (deoxyadenosine), and 530 (de- 
oxycytidine). A representative FAB precursor ion spec- 
trum (257 u) for the anti-BaPDE deoxyadenosine 
adduct is shown in Figure 7. The detection limit for 
this approach was typically around 10 ng. 
Derivutized adducts. With underivatized adducts, pre- 
cursor ion scans were based upon the PAH moiety 
(i.e., fragment 3 in Scheme I). TMS-derivatized adducts 
proved to be of greater utility for precursor ion scans 
because the m/z 191 ion was not dependent on either 
the PAH or the deoxynucleoside. (This ion, m/z 191, 
has not been observed from TMS derivatives of other 
types of DNA adducts or from the TMS derivatization 
of biological and matrix blanks.) Thus, by using TMS- 
derivatized adducts, information could be obtained on 
both the PAH dihydrodiol-epoxide and the deoxynu- 
cleoside. As an example, Figure 8 shows a precursor 
ion scan from DNA that had been reacted with alzti- 
BaPDE, enzymatically digested to deoxynucleosides, 
and then derivatized with TMSI. Two adducts were 
apparent: one was derived from deoxyguanosine, as 
evident from ions of m/z 858, 786, and 670, which 
represent the tetrukis- and tris-TMS derivatives of the 
protonated molecule and the tris-TMS derivative of 
BH:, respectively. The other adduct resulted from 
deoxyadenosine, as indicated by the ion of m/z 677, 
which results from the tris-TMS BHNa+ derivative. 
To determine the utility of this technique for the 
analysis of mixtures that contain deoxynucleoside 
adducts from different PAH dihydrodiol-epoxides, 
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Figure 7. FAB precursor ion spectrum 011/z 257) for fi&BaPDE 
deoxyadenosine adduct. 








c EH No' I IVS I 3 
2 60 677 
0 








Figure 8. FAB precursor ion spectrum (m/z 191) of DNA re- 
acted with anti-BaPDE. Following enzymatic hydrolysis to de- 
oxynucleosides, the hydrolysate was derivatized with Th4SI. 
DNA was reacted with anti-BaPDE, anti-chrysene di- 
hydrodiol-epoxide, and anti-dibenz[ a,c]-anthracene di- 
hydrodiol-epoxide. The modified DNA was then hy- 
drolyzed enzymatically to deoxynucleosides that were 
derivatized with TMSI. HPLC-UV analysis of the de- 
oxynucleoside mixture before derivatization indicated 
the presence of the three deoxyguanosine adducts in a 
4.2:5.8:1.0 ratio; however, only those adducts that re- 
sulted from reactions with anti-BaPDE and anti-chry- 
sene dihydrodiol-epoxide were detected in the precur- 
sor ion scans (Figure 9). The ions of m/z 670, 786, and 
858 corresponded, respectively, to the his-TMS deriva- 
tive of BHT and the his- and tetrnkis-TMS derivatives 
of the protonated molecule of the anti-BaPDE de- 
oxyguanosine adduct. Likewise, the ion of m/t 646 
and perhaps the weaker signals for m/z 762 and 834 
may be attributed to the tris-TMS derivative of BH: 
and the tris- and tetrukis-TMS derivatives of the pro& 
nated molecule of the &i-chrysene dihydrodiol- 
epoxide deoxyguanosine adduct. In addition, an unti- 
BaPDE deoxyadenosine adduct was suggested by the 
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Figure 9. FAB precursor ion spectrum On/z 191) of DNA re- 
acted with anti-BaPDE, nnti-chrysene dihydrodiol-epoxide 
(ChryDE), and anti-dibenz[ n,c]anthracene dihydrodiol-epoxide. 
Following enzymatic hydrolysis to deoxynucleosides, the hydra 
lysate was derivatized with TMSI. 
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Figure 10. FAB mass spectrum of DNA reacted with anti- 
BaPDE, nnti-chrysene dihydrodiol-epoxide, and anti- 
dibenz[ n,c]anthracene dihydrodiol-epoxide (DBADE). Following 
enzymatic hydrolysis to deoxynucleosides, the hydrolysate was 
derivatized with TMSI. 
presence of a weak ion of m/z 677, which corre- 
sponded to the tris-TMS BHNa+ derivative. 
Constant neutral loss scans were obtained on the 
same mixture and only adducts obtained from anti- 
BaPDE and anti-chrysene dihydrodiol-epoxide could 
be identified (spectra not shown); however, a FAB full 
scan spectrum (Figure 10) showed a small fragment 
ion of m/z 696 that corresponded to the tris-TMS 
derivative of the BH: of the deoxyguanosine 
dibenz[ a,c]-anthracene dihydrodiol-epoxide adduct. 
The failure to detect this adduct in precursor ion or 
constant neutral loss scans is probably due to its low 
concentration relative to the other two deoxyguanosine 
adducts in the DNA sample. 
Conclusions 
These studies used three different experimental tech- 
niques (product ion, constant neutral loss, and precur- 
sor ion scans> to investigate PAH dihydrodiol-epoxide 
deoxynucleoside adducts. The results indicate that FAB 
tandem mass spectrometry has significant potential 
for the detection and structural characterization of 
PAH-dihydrodiol-epoxide as well as arylamine-DNA 
adducts, and the most appropriate technique depends 
on the specific adduct (e.g., class of carcinogen) and 
the information desired from the experiment. With a 
DNA adduct that results from a dihydrodiol-epoxide 
of an unknown PAH, for example, constant neutral 
loss scans based upon loss of 313 u (for deoxyguano- 
sine adducts) proved to be a very sensitive method for 
PAH identification. Although this method may be ap- 
plicable only to PAH dihydrodiol-epoxide adducts of 
deoxyguanosine, this particular deoxynucleoside is 
typically the major site for adduct formation in DNA 
PI. 
In instances where the identity of the PAH dihydro- 
diol-epoxide is known, a precursor ion scan based 
upon a PAH fragment (i.e., fragment 3 in Scheme I) 
can be used to identify the molecular weight of the 
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adduct and, hence, the deoxynucleoside. Alternatively, 
the mass of PAH dihydrodiol-epoxide initially can be 
determined by using constant neutral loss scans (313 
or 116 u) and this can be followed by precursor ion 
scans to identify the deoxynucleoside. For adducts that 
result from carcinogens other than PAH dihydrodiol- 
epoxides, constant neutral loss scans of 116 u, which 
represents the loss of deoxyribose, can be used to 
determine the molecular weight of the adduct, and 
then product ion scans can readily distinguish aryl- 
amine from PAH dihydrodiol-epoxide adducts due to 
abundant losses (e.g., 313 u for the deoxy-guanosine- 
PAH adduct) from the dihydrodiol-epoxide adducts. 
Because of the more extensive fragmentation ob- 
served from the protonated molecules of PAH dihy- 
drodiol-epoxide adducts, it is not necessary to conduct 
product ion studies using BH: ions, as was the case 
with the arylamine adducts previously studied [17]. 
Preparation of TMS derivatives increased the sensitiv- 
ity of adduct detection. Precursor ion scans of these 
TMS derivatives, by using a 191-u fragment, allowed 
simultaneous detection of several DNA adducts in a 
mixture. These results suggest potential applications of 
tandem mass spectrometry techniques to the identifi- 
cation of PAH dihydrodiol-epoxide derived carcino- 
gen-DNA adducts. 
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